Thermo Fisher Scientific TMO Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Thermo Fisher Scientific's deferred revenue?
- Thermo Fisher Scientific (TMO) reported deferred revenue of $2.93B in Q1 2026.
- How has Thermo Fisher Scientific's deferred revenue changed year-over-year?
- Thermo Fisher Scientific's deferred revenue increased by 2.2% year-over-year, from $2.87B to $2.93B.
- What is the long-term trend for Thermo Fisher Scientific's deferred revenue?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's deferred revenue has grown at a 16.3% compound annual growth rate (CAGR), from $1.27B to $2.71B.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.